Embrace true customer-centricity to build future readiness
Life sciences companies take pride in their purpose to make innovative and affordable healthcare accessible around their world. Align your future-readiness vision with this customer, the patient themselves. Rally internal and external stakeholders around the patient, personalize their engagement by leveraging data across the value chain, embrace new technologies and processes to shorten the time from drug discovery to commercialization. This helps bring the right product to the right patient at the right time.
Adopt emerging technology for targeted use cases to stay ahead
As life sciences development-to-commercialization model evolves, adopt emerging technology to modernize every element of the value chain. Leverage RWD, RWE and a decentralized approach to accelerate and improve success rate of clinical trials. Improve the efficiency of regulatory submissions with generative AI-driven insights on new regulations and effective submission authoring. Educate and engage HCPs through granular data on digital affinity to segment and target them effectively and reach them when and where they like to be engaged. Reduce cost and improve quality of pharmacovigilance operations through AI and NLP-driven automation.
Build operations agility and financial resilience to invest in growth
Research and development and sales and marketing costs account for over 40% of a life sciences company’s sales. As compliance requirements grow and new regulations such as the Inflation Reduction Act (IRA) put pressure on margins, drive productivity through automation, an optimal mix of global, regional and local operations, and partnerships with the larger ecosystem. Reinvest the efficiency gains into building a pipeline of innovative products and accelerate clinical development with a modern, data-driven approach. Extend the experimentation and innovation mindset from the left side of the value chain (research and development) to the right (sales and marketing).
Visibly demonstrate leadership commitment and manage change effectively for future success
Life sciences companies are modernizing operations across the drug discovery and research through commercialization continuum. As their talent demographic evolves and life sciences leaders onboard talent from other industries, startups and universities, they need to visibly demonstrate their commitment to being future-ready and manage change effectively. Invest in technologies you truly believe have the potential, complement technology talent with life sciences knowledge, and break down siloes across the organization.